Atlas Trials

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Clinical trial NCT06902246 · WITHDRAWN

Trial details

NCT number
NCT06902246
Sponsor
University of Miami
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
Start date
2026-08-01
Primary completion
2031-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.